Targeting the HIF2–VEGF axis in renal cell carcinoma
Brigham and Women's Hospital · Harvard University · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
470
total citations
- FWCI
- 23.45
- Percentile
- 100%
- References
- 181
Citations per year
Authors
2- TKToni K. ChoueiriCorresponding
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- WGWilliam G. Kaelin
Brigham and Women's Hospital, Howard Hughes Medical Institute, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Topics & keywords
Topics
Keywords
- Hypoxia-inducible factors
- Cancer research
- Clear cell renal cell carcinoma
- Renal cell carcinoma
- Transcription factor
- Medicine
- HIF1A
- Immune checkpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.